透雲生物(01332.HK)獲得中國國家衞生健康委員會正式批准萊茵衣藻為新食品原料
格隆匯5月13日丨透雲生物(01332.HK)公吿,公司全資附屬公司山西透雲生物科技有限公司於2022年5月11日獲得中國國家衞生健康委員會正式批准萊茵衣藻為新食品原料,可以不限量食用。此批准及集團前期於中國山西省長治市潞城區成功建成第一期生產萊茵衣藻的廠房(年產4,000噸萊茵衣藻),令集團為推動萊茵衣藻於中國的市場業務發展有重大的幫助。
萊茵衣藻是來自於自然界的天然微藻,被譽為是色細胞工廠和色酵母。其優異的蛋白及豐富的微量元素組合對人體的健康有着極為重要的意義。
集團採用專有發酵技術生產萊茵衣藻,不佔用大量土地及不受環境污染和氣候影響,保證產品質量及成本控制。萊茵衣藻以其獨特屬性可以批量加入到食品及飲料中,成為人類的一種全新可食用植物蛋白來源。同時,公司為工廠化生產植物蛋白減少碳排放、減輕糧食危機提供有效方案。
本次批准的是萊茵衣藻綠藻,其主要用途為批量加入到麪食、飲品和奶製品中以提高健康功效。本集團的萊茵衣藻紅藻(人造肉和人造魚製品原料)及萊茵衣藻的白藻(植物奶製品原料)的新食品原料的申報已在進行中。
由於人們越來越注重健康,公司董事會認為萊茵衣藻及微藻產品市場具有特別增長潛力。生產及銷售萊茵衣藻產品將有助多元化集團業務及擴大其收入來源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.